Divalproex Sodium Capsule, Delayed Release
Product Images NDC 55154-3552

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 55154-3552). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag Label (0816a066 9ee3 4c23 944d 3539fc2c12bf 00)

Text panel for Divalproex sodium delayed-release capsules USP, 125 mg, describing capsule contents, dosage, storage conditions, dispensing instructions, and warnings. It includes directions for pharmacists to provide a medication guide and specifies the product is prescription only. Manufacturer and distributor information are also listed.*

FDA Label Image

Figure1 (Figure1)

A line chart comparing the percentage reduction in CPS (Clinical Profile Score) rate between Divalproex Sodium and placebo across a patient population. The vertical axis represents % reduction in CPS rate, ranging from -100% to 100%, while the horizontal axis shows the percentage of patients. The chart indicates improvement or worsening based on the direction of the CPS rate change, with separate lines for Divalproex Sodium and placebo.*

FDA Label Image

Figure2 (Figure2)

A cumulative distribution graph showing percent reduction in CPS rate on the vertical axis and percent of patients on the horizontal axis, comparing high dose and low dose treatments. The graph indicates improvement or worsening with labeled axes, using solid and dashed lines to distinguish high and low doses.*

FDA Label Image

Picture1 (Picture1)

Divalproex sodium 125 mg delayed-release capsules bottle label. The image shows a small white capsule bottle with a black cap, partially visible text on the label includes the word 'DRY.' The labeler is Cardinal Health 107, LLC, and the product is an oral human prescription drug.*

FDA Label Image

Picture2 (Picture2)

Divalproex sodium 125 mg delayed release capsules label showing the capsule held between two fingers. The capsule appears to have imprint text on it, partially visible as 'DY 5'. The labeler is Cardinal Health 107, LLC, and the product is for oral human prescription use.*

FDA Label Image

Picture3 (Picture3)

Divalproex sodium 125 mg delayed-release capsules in a black and white image showing a capsule partially open with granules spilling out. The dosage form is oral capsules. The product is labeled by Cardinal Health 107, LLC.*

FDA Label Image

Picture4 (Picture4)

An instructional illustration showing a person swallowing an oral capsule with water, demonstrating the proper method of taking a delayed-release capsule orally.*

FDA Label Image

Structure (Structure)

Chemical structure of divalproex sodium showing the molecular arrangement including sodium ion and valproate groups. The diagram depicts the chemical formula components within parentheses indicating polymerization.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.